Companion Animal Pharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1067318
  • December 2021
  • Pharmaceuticals
  • 154 Pages
Report Description

This report is a comprehensive study that examines the Companion Animal Pharmaceuticals industry in depth. With reference to key regions and major nations, the study specifies the product type of Companion Animal Pharmaceuticals as well as its use in various industrial verticals. Furthermore, the report identified and analysed all of the top companies functioning in the global Companion Animal Pharmaceuticals market arena, comparing and contrasting them based on market revenue, yearly sales volume, historical growth rate, and company strategies. The worldwide Companion Animal Pharmaceuticals market research offers a business strategy for current market participants to strengthen their market positions based on all of these findings. Furthermore, the paper recommends a market entry strategy for newcomers to the sector.

The top vendors and distributors operating in all of the major regions have also been highlighted in the Companion Animal Pharmaceuticals market report. This data and research should aid market players in strengthening their market distribution networks and expanding their geographic reach.
 
Companion Animal Pharmaceuticals Market Strategic Analysis 

The market was studied using several marketing methodologies such as Porter's Five Forces Analysis, player positioning analysis, SWOT analysis, market share analysis, and value chain analysis in the Companion Animal Pharmaceuticals market study. The market dynamics and factors such as the threat of a Companion Animal Pharmaceuticals substitute, the threat of new entrants into the Companion Animal Pharmaceuticals market, buyer bargaining power, supplier bargaining power to Companion Animal Pharmaceuticals providing companies, and internal rivalry among Companion Animal Pharmaceuticals providers are analysed in Porter's Five Forces analysis to provide the report's readers with a detailed view of the current market dynamics.

This analysis assists report users in evaluating the Companion Animal Pharmaceuticals market based on various parameters such as economies of scale, switching costs, brand loyalty, existing distribution channels, capital investments, manufacturing rights & patents, government regulations, advertising impact, and consumer preference impact. This simplified data is expected to aid the industry's key decision-makers in their decision-making process. Furthermore, this study answers the crucial question of whether or not new entrants should enter the Companion Animal Pharmaceuticals industry.
 
Companion Animal Pharmaceuticals Market Key Trends Analysis

The important factors influencing the growth of the Companion Animal Pharmaceuticals market have been examined in this report. The driving factors that are boosting demand for Companion Animal Pharmaceuticalss and the restraining factors that are slowing growth of the Companion Animal Pharmaceuticals industry are addressed in depth, as well as their implications for the worldwide Companion Animal Pharmaceuticals market. In addition, the published analysis identifies and discusses in detail the trends that are driving the market and impacting its growth. In addition, other qualitative variables such as risks connected with operations and key problems faced by market players are covered in the report.

Companion Animal Pharmaceuticals Market Key Segment Analysis

By segmenting the market by product type, application, and geography, the study provides a clear picture of the Companion Animal Pharmaceuticals industry. On the basis of current and future trends, all segments of the Companion Animal Pharmaceuticals industry have been examined. The market and its divisions are forecasted for the years 2021 through 2028. The study identifies the categories that are contributing the most to total market revenue growth, as well as the factors that are supporting their growth.

The research will provide a detailed qualitative and quantitative product type segment analysis for the years 2021 to 2028.

The report study analyses and includes a variety of prospective prospects and aspects affecting various applications.
 
Companion Animal Pharmaceuticals Market Regional Trends and Market Player’s Analysis

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the regions in which the market is divided. In 2020, the worldwide Companion Animal Pharmaceuticals market was dominated by North America. The Asia Pacific region is expected to have the highest CAGR for the Companion Animal Pharmaceuticals market throughout the projected period.


 
The market revenue, market shares, business strategies, recent developments, and growth rates of major players with substantial market shares in the global Companion Animal Pharmaceuticals market are all examined. These firms' recent developments, such as new solution/product launches, research projects, acquisitions, geographic expansions, and technological advancements, are taken into account when determining their position in the Companion Animal Pharmaceuticals market. All important stakeholders in the Companion Animal Pharmaceuticals value chain and technological ecosystem are expected to benefit from the insights offered in the Companion Animal Pharmaceuticals market research study.

In order to provide a broader understanding of the top competitors in the Companion Animal Pharmaceuticals market, the research includes a company market share analysis. Ashish Life Science Pvt. Ltd., Boehringer Ingelheim GmbH, Ceva Santé Animale, Chanelle Pharma, Dechra Pharmaceuticals plc, Eco Animal Health Group plc, Elanco Animal Health Incorporated, Endovac Animal Health, Hipra, Indian Immunologicals Ltd., Inovet, Kyoritsu Seiyaku, Lutim Pharma Pvt. Ltd., Merck & Co. Inc., Norbrook Holdings Limited, Tianjin Ringpu Bio-Technology Co. Ltd., Vetoquinol S.A. are among the major participants in the global Companion Animal Pharmaceuticals industry.
 
Scope of the report
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2021
Forecast Period Covered 2021-2028
Units for value Revenue in USD million and CAGR from 2021 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Ashish Life Science Pvt. Ltd., Boehringer Ingelheim GmbH, Ceva Santé Animale, Chanelle Pharma, Dechra Pharmaceuticals plc, Eco Animal Health Group plc, Elanco Animal Health Incorporated, Endovac Animal Health, Hipra, Indian Immunologicals Ltd., Inovet, Kyoritsu Seiyaku, Lutim Pharma Pvt. Ltd., Merck & Co. Inc., Norbrook Holdings Limited, Tianjin Ringpu Bio-Technology Co. Ltd., Vetoquinol S.A.
 
Major Highlights of the Companion Animal Pharmaceuticals Market report study:
  • An in-depth examination of the global Companion Animal Pharmaceuticals industry will be published soon.
  • The study examines the global Companion Animal Pharmaceuticals market and offers major actionable information to its players.
  • The research has taken into account all key events in the recent past, providing users with up-to-date industry information.
  • The report study is expected to aid the industry's key decision-makers in their decision-making process.
  • Data on market intelligence, changing market dynamics, existing and predicted market trends, and so on are included in the report.
  • The research includes a detailed examination of the macroeconomic and microeconomic aspects that influence the global Companion Animal Pharmaceuticals industry.
  • The Market Ecosystem and Adoption in Different Markets
  • The global Companion Animal Pharmaceuticals market is being shaped by several major trends.
  • The size of the Companion Animal Pharmaceuticals market in terms of revenue has been measured in the past and will be measured in the future in USD million.
  • Consumer preference patterns and recent industrial developments
  • The worldwide Companion Animal Pharmaceuticals market's competitive landscape and player positioning analysis
  • Major players' key goods and solutions, as well as their business strategies
  • Recommendations for new market entrants as well as existing market participants.
  • The study of niche and potential segments (product type, application, and regions/countries) predicts that promising growth will be noticed.
  • Operating players in the market encounter a number of significant hurdles.
  • An examination of the major risks involved in market operations
 
The report segment of the global Companion Animal Pharmaceuticals market as follows:
Global Companion Animal Pharmaceuticals Market: By Product Type

  • Cats
  • Dogs
  • Horses

Global Companion Animal Pharmaceuticals Market: By Application
  • Retail Pharmacies
  • Veterinary Clinics
  • Veterinary Hospitals

Global Companion Animal Pharmaceuticals Market: By Region
  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China 
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The report study is drafted to provide actionable insights to the following mentioned audience:
  • Institutes of research and consulting firms
  • Companies are attempting to get into the Companion Animal Pharmaceuticals market.
  • Universities and students
  • Other companies in the Companion Animal Pharmaceuticals market include solution providers, product producers, service providers, and others.
  • Private companies and government agencies that are linked
  • Individuals interested in learning more about the Companion Animal Pharmaceuticals market

Manufacturers and Segments

  • Ashish Life Science Pvt. Ltd.
  • Boehringer Ingelheim GmbH
  • Ceva Santé Animale
  • Chanelle Pharma
  • Dechra Pharmaceuticals plc
  • Eco Animal Health Group plc
  • Elanco Animal Health Incorporated
  • Endovac Animal Health
  • Hipra
  • Indian Immunologicals Ltd.
  • Inovet
  • Kyoritsu Seiyaku
  • Lutim Pharma Pvt. Ltd.
  • Merck & Co. Inc.
  • Norbrook Holdings Limited
  • Tianjin Ringpu Bio-Technology Co. Ltd.
  • Vetoquinol S.A.
  • Cats
  • Dogs
  • Horses
  • Retail Pharmacies
  • Veterinary Clinics
  • Veterinary Hospitals

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Companion Animal Pharmaceuticals Market Snapshot
          2.1.1. Global Companion Animal Pharmaceuticals Market By Cats,2019
               2.1.1.1.
               2.1.1.2.Cats
               2.1.1.3.Dogs
          2.1.2. Global Companion Animal Pharmaceuticals Market By Retail Pharmacies,2019
               2.1.2.1.
               2.1.2.2.Retail Pharmacies
               2.1.2.3.Veterinary Clinics
          2.1.3. Global Companion Animal Pharmaceuticals Market By End-use,2019
          2.1.4. Global Companion Animal Pharmaceuticals Market By Geography,2019

3. Global Companion Animal Pharmaceuticals Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Companion Animal Pharmaceuticals Market Size (US$), By Cats, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Cats, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Cats, 2020
     4.2. Global Companion Animal Pharmaceuticals Market Size (US$), By Cats, 2018 – 2028

5. Global Companion Animal Pharmaceuticals Market Size (US$), By Retail Pharmacies, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Retail Pharmacies, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Retail Pharmacies, 2020
     5.2. Global Companion Animal Pharmaceuticals Market Size (US$), By Retail Pharmacies, 2018 – 2028

6. Global Companion Animal Pharmaceuticals Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Companion Animal Pharmaceuticals Market Size (US$), By End-use, 2018 – 2028

7. Global Companion Animal Pharmaceuticals Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Companion Animal Pharmaceuticals Market Analysis, 2018 – 2028 
          7.2.1. North America Companion Animal Pharmaceuticals Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Companion Animal Pharmaceuticals Market Size (US$), By Cats, 2018 – 2028
          7.2.3. North America Companion Animal Pharmaceuticals Market Size (US$), By Retail Pharmacies, 2018 – 2028
          7.2.4. North America Companion Animal Pharmaceuticals Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Companion Animal Pharmaceuticals Market Analysis, 2018 – 2028 
          7.3.1.  Europe Companion Animal Pharmaceuticals Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Companion Animal Pharmaceuticals Market Size (US$), By Cats, 2018 – 2028
          7.3.3. Europe Companion Animal Pharmaceuticals Market Size (US$), By Retail Pharmacies, 2018 – 2028
          7.3.4. Europe Companion Animal Pharmaceuticals Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Companion Animal Pharmaceuticals Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Companion Animal Pharmaceuticals Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Companion Animal Pharmaceuticals Market Size (US$), By Cats, 2018 – 2028
          7.4.3. Asia Pacific Companion Animal Pharmaceuticals Market Size (US$), By Retail Pharmacies, 2018 – 2028
          7.4.4. Asia Pacific Companion Animal Pharmaceuticals Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Companion Animal Pharmaceuticals Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Companion Animal Pharmaceuticals Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Companion Animal Pharmaceuticals Market Size (US$), By Cats, 2018 – 2028
          7.5.3. Latin America Companion Animal Pharmaceuticals Market Size (US$), By Retail Pharmacies, 2018 – 2028
          7.5.4. Latin America Companion Animal Pharmaceuticals Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Companion Animal Pharmaceuticals Market Analysis, 2018 – 2028 
          7.6.1.  MEA Companion Animal Pharmaceuticals Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Companion Animal Pharmaceuticals Market Size (US$), By Cats, 2018 – 2028
          7.6.3. MEA Companion Animal Pharmaceuticals Market Size (US$), By Retail Pharmacies, 2018 – 2028
          7.6.4. MEA Companion Animal Pharmaceuticals Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Companion Animal Pharmaceuticals Providers
        8.4.1 Ashish Life Science Pvt. Ltd.
                8.4.1.1 Business Description
                8.4.1.2 Ashish Life Science Pvt. Ltd. Geographic Operations
                8.4.1.3 Ashish Life Science Pvt. Ltd. Financial Information
                8.4.1.4 Ashish Life Science Pvt. Ltd. Product Positions/Portfolio
                8.4.1.5 Ashish Life Science Pvt. Ltd. Key Developments
        8.4.2 Boehringer Ingelheim GmbH
                8.4.2.1 Business Description
                8.4.2.2 Boehringer Ingelheim GmbH Geographic Operations
                8.4.2.3 Boehringer Ingelheim GmbH Financial Information
                8.4.2.4 Boehringer Ingelheim GmbH Product Positions/Portfolio
                8.4.2.5 Boehringer Ingelheim GmbH Key Developments
        8.4.3 Ceva Santé Animale
                8.4.3.1 Business Description
                8.4.3.2 Ceva Santé Animale Geographic Operations
                8.4.3.3 Ceva Santé Animale Financial Information
                8.4.3.4 Ceva Santé Animale Product Positions/Portfolio
                8.4.3.5 Ceva Santé Animale Key Developments
        8.4.4 Chanelle Pharma
                8.4.4.1 Business Description
                8.4.4.2 Chanelle Pharma Geographic Operations
                8.4.4.3 Chanelle Pharma Financial Information
                8.4.4.4 Chanelle Pharma Product Positions/Portfolio
                8.4.4.5 Chanelle Pharma Key Developments
        8.4.5 Dechra Pharmaceuticals plc
                8.4.5.1 Business Description
                8.4.5.2 Dechra Pharmaceuticals plc Geographic Operations
                8.4.5.3 Dechra Pharmaceuticals plc Financial Information
                8.4.5.4 Dechra Pharmaceuticals plc Product Positions/Portfolio
                8.4.5.5 Dechra Pharmaceuticals plc Key Developments
        8.4.6 Eco Animal Health Group plc
                8.4.6.1 Business Description
                8.4.6.2 Eco Animal Health Group plc Geographic Operations
                8.4.6.3 Eco Animal Health Group plc Financial Information
                8.4.6.4 Eco Animal Health Group plc Product Positions/Portfolio
                8.4.6.5 Eco Animal Health Group plc Key Developments
        8.4.7 Elanco Animal Health Incorporated
                8.4.7.1 Business Description
                8.4.7.2 Elanco Animal Health Incorporated Geographic Operations
                8.4.7.3 Elanco Animal Health Incorporated Financial Information
                8.4.7.4 Elanco Animal Health Incorporated Product Positions/Portfolio
                8.4.7.5 Elanco Animal Health Incorporated Key Developments
        8.4.8 Endovac Animal Health
                8.4.8.1 Business Description
                8.4.8.2 Endovac Animal Health Geographic Operations
                8.4.8.3 Endovac Animal Health Financial Information
                8.4.8.4 Endovac Animal Health Product Positions/Portfolio
                8.4.8.5 Endovac Animal Health Key Developments
        8.4.9 Hipra
                8.4.9.1 Business Description
                8.4.9.2 Hipra Geographic Operations
                8.4.9.3 Hipra Financial Information
                8.4.9.4 Hipra Product Positions/Portfolio
                8.4.9.5 Hipra Key Developments
        8.4.10 Indian Immunologicals Ltd.
                8.4.10.1 Business Description
                8.4.10.2 Indian Immunologicals Ltd. Geographic Operations
                8.4.10.3 Indian Immunologicals Ltd. Financial Information
                8.4.10.4 Indian Immunologicals Ltd. Product Positions/Portfolio
                8.4.10.5 Indian Immunologicals Ltd. Key Developments
        8.4.11 Inovet
                8.4.11.1 Business Description
                8.4.11.2 Inovet Geographic Operations
                8.4.11.3 Inovet Financial Information
                8.4.11.4 Inovet Product Positions/Portfolio
                8.4.11.5 Inovet Key Developments
        8.4.12 Kyoritsu Seiyaku
                8.4.12.1 Business Description
                8.4.12.2 Kyoritsu Seiyaku Geographic Operations
                8.4.12.3 Kyoritsu Seiyaku Financial Information
                8.4.12.4 Kyoritsu Seiyaku Product Positions/Portfolio
                8.4.12.5 Kyoritsu Seiyaku Key Developments
        8.4.13 Lutim Pharma Pvt. Ltd.
                8.4.13.1 Business Description
                8.4.13.2 Lutim Pharma Pvt. Ltd. Geographic Operations
                8.4.13.3 Lutim Pharma Pvt. Ltd. Financial Information
                8.4.13.4 Lutim Pharma Pvt. Ltd. Product Positions/Portfolio
                8.4.13.5 Lutim Pharma Pvt. Ltd. Key Developments
        8.4.14 Merck & Co. Inc.
                8.4.14.1 Business Description
                8.4.14.2 Merck & Co. Inc. Geographic Operations
                8.4.14.3 Merck & Co. Inc. Financial Information
                8.4.14.4 Merck & Co. Inc. Product Positions/Portfolio
                8.4.14.5 Merck & Co. Inc. Key Developments
        8.4.15 Norbrook Holdings Limited
                8.4.15.1 Business Description
                8.4.15.2 Norbrook Holdings Limited Geographic Operations
                8.4.15.3 Norbrook Holdings Limited Financial Information
                8.4.15.4 Norbrook Holdings Limited Product Positions/Portfolio
                8.4.15.5 Norbrook Holdings Limited Key Developments
        8.4.16 Tianjin Ringpu Bio-Technology Co. Ltd.
                8.4.16.1 Business Description
                8.4.16.2 Tianjin Ringpu Bio-Technology Co. Ltd. Geographic Operations
                8.4.16.3 Tianjin Ringpu Bio-Technology Co. Ltd. Financial Information
                8.4.16.4 Tianjin Ringpu Bio-Technology Co. Ltd. Product Positions/Portfolio
                8.4.16.5 Tianjin Ringpu Bio-Technology Co. Ltd. Key Developments
        8.4.17 Vetoquinol S.A.
                8.4.17.1 Business Description
                8.4.17.2 Vetoquinol S.A. Geographic Operations
                8.4.17.3 Vetoquinol S.A. Financial Information
                8.4.17.4 Vetoquinol S.A. Product Positions/Portfolio
                8.4.17.5 Vetoquinol S.A. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Companion Animal Pharmaceuticals Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Companion Animal Pharmaceuticals Market Revenue, By Cats, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Companion Animal Pharmaceuticals Market Revenue, By Retail Pharmacies, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Companion Animal Pharmaceuticals Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Companion Animal Pharmaceuticals Market Revenue, By Cats, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Companion Animal Pharmaceuticals Market Revenue, By Retail Pharmacies, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Companion Animal Pharmaceuticals Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Companion Animal Pharmaceuticals Market Revenue, By Cats, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Companion Animal Pharmaceuticals Market Revenue, By Retail Pharmacies, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Companion Animal Pharmaceuticals Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Companion Animal Pharmaceuticals Market Revenue, By Cats, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Companion Animal Pharmaceuticals Market Revenue, By Retail Pharmacies, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Companion Animal Pharmaceuticals Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Companion Animal Pharmaceuticals Market Revenue, By Cats, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Companion Animal Pharmaceuticals Market Revenue, By Retail Pharmacies, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Companion Animal Pharmaceuticals Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Companion Animal Pharmaceuticals: Market Segmentation 
FIG. 2 Global Companion Animal Pharmaceuticals Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Companion Animal Pharmaceuticals Market, By Cats, 2019 (US$ Mn) 
FIG. 5 Global Companion Animal Pharmaceuticals Market, By Retail Pharmacies, 2019 (US$ Mn) 
FIG. 6 Global Companion Animal Pharmaceuticals Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Companion Animal Pharmaceuticals Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Companion Animal Pharmaceuticals Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Companion Animal Pharmaceuticals Providers, 2019
FIG. 11 Global Companion Animal Pharmaceuticals Market Revenue Contribution, By Cats, 2019 & 2028 (Value %) 
FIG. 12 Global Companion Animal Pharmaceuticals Market Revenue Contribution, By Retail Pharmacies, 2019 & 2028 (Value %) 
FIG. 13 Global Companion Animal Pharmaceuticals Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Companion Animal Pharmaceuticals Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Companion Animal Pharmaceuticals Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Companion Animal Pharmaceuticals Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Companion Animal Pharmaceuticals Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Companion Animal Pharmaceuticals Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Companion Animal Pharmaceuticals market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Companion Animal Pharmaceuticals Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Companion Animal Pharmaceuticals Market Value, By Segment1, 2018 – 2028
TABLE  North America Companion Animal Pharmaceuticals Market Value, By Segment2, 2018 – 2028
TABLE  North America Companion Animal Pharmaceuticals Market Value, By Country, 2018 – 2028
TABLE  Europe Companion Animal Pharmaceuticals Market Value, By Segment1, 2018 – 2028
TABLE  Europe Companion Animal Pharmaceuticals Market Value, By Segment2, 2018 – 2028
TABLE  Europe Companion Animal Pharmaceuticals Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Companion Animal Pharmaceuticals Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Companion Animal Pharmaceuticals Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Companion Animal Pharmaceuticals Market Value, By Country, 2018 – 2028
TABLE  Latin America Companion Animal Pharmaceuticals Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Companion Animal Pharmaceuticals Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Companion Animal Pharmaceuticals Market Value, By Country, 2018 – 2028
TABLE  MEA Companion Animal Pharmaceuticals Market Value, By Segment1, 2018 – 2028
TABLE  MEA Companion Animal Pharmaceuticals Market Value, By Segment2, 2018 – 2028
TABLE  MEA Companion Animal Pharmaceuticals Market Value, By Country, 2018 – 2028
TABLE  Ashish Life Science Pvt. Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Boehringer Ingelheim GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Ceva Santé Animale: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Chanelle Pharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Dechra Pharmaceuticals plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eco Animal Health Group plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Elanco Animal Health Incorporated: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Endovac Animal Health: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Hipra: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Indian Immunologicals Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Inovet: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Kyoritsu Seiyaku: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Lutim Pharma Pvt. Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co. Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Norbrook Holdings Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Tianjin Ringpu Bio-Technology Co. Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Vetoquinol S.A.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Companion Animal Pharmaceuticals Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Companion Animal Pharmaceuticals Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Companion Animal Pharmaceuticals Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Companion Animal Pharmaceuticals Market, By Geography, 2019 (US$ Mn)
FIG.  Global Companion Animal Pharmaceuticals Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Companion Animal Pharmaceuticals Providers, 2016
FIG.  Global Companion Animal Pharmaceuticals Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Cats Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Dogs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Horses Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Companion Animal Pharmaceuticals Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Retail Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Veterinary Clinics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Veterinary Hospitals Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Companion Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Companion Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Companion Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Companion Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Companion Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Companion Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Companion Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Companion Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Companion Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Companion Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Companion Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Companion Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Companion Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Companion Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Companion Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Companion Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)